Oct 31 (Reuters) - U.S. drugmaker Regeneron Pharmaceuticals ( REGN ) beat Wall Street estimates for third-quarter profit and revenue on Thursday, driven by strong demand for its eczema treatment Dupixent and blockbuster eye disease drug Eylea. Regeneron has been looking to upgrade patients who use Eylea to a high-dose version, as the drug that has long been its cash...

Oct 31 (Reuters) - Engie has signed a deal with Facebook owner Meta Platforms ( META ) for the U.S. social media group to buy 100% of the output from its U.S. Sypert solar power plant, the French utility said on Thursday. The plant is expected to start operating in late 2025, Engie said. Once operational, it will add to...

07:21 AM EDT, 10/31/2024 (MT Newswires) -- Estee Lauder ( EL ) reported fiscal Q1 adjusted earnings Thursday of $0.14 per diluted share, up from $0.11 a year earlier. Analysts polled by Capital IQ expected $0.10. Net sales for the quarter ended Sept. 30 were $3.36 billion, down from $3.52 billion a year earlier. Analysts surveyed by Capital IQ expected...

07:21 AM EDT, 10/31/2024 (MT Newswires) -- The Canadian province of Ontario is projecting a C$6.6 billion deficit for FY24/25 or roughly 0.6% of gross domestic product, notably smaller than the C$9.8 billion shortfall estimated in the initial budget plan, noted Bank of Montreal (BMO). Considering that the mid-year fiscal update came with a strong dose of new spending measures...